Last checked at 22 Sep 2020 07:43
LONDON MARKET PRE-OPEN: Whitbread Sales Slump, Plans To Axe 6,000 Jobs
LONDON MARKET PRE-OPEN: Whitbread Sales Slump, Plans To Axe 6,000 Jobs
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades
HIK
Live RNS
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions
HIK
Media
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,854.00
Bid:
1,750.00
Ask:
1,950.00
Change:
0.00 (0.00%)
Spread:
200.00 (11.429%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
1,854.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.18 Sep 2020 12:19
UPDATE 2-EU regulator backs dexamethasone as COVID-19 treatment
* EMA says drug could be option for severely ill patients* Recommends dosage of 6 mg once a day for up to 10 days* Gilead's Veklury already approved for COVID-19 in EU (Recasts, adds details on drug, background)By Pushkala Aripaka and Yadarisa Shabo...
Read more14 Sep 2020 15:44
8 Sep 2020 09:31
UK BROKER RATINGS SUMMARY: Barclays Cuts GVC And Raises Flutter
UK BROKER RATINGS SUMMARY: Barclays Cuts GVC And Raises Flutter
Read more4 Sep 2020 17:09
LONDON MARKET CLOSE: Housebuilders Drag FTSE 100 Into Red
LONDON MARKET CLOSE: Housebuilders Drag FTSE 100 Into Red
Read more4 Sep 2020 13:53
Friday broker round-up
(Sharecast News) - Imperial Brands: JP Morgan upgrades to overweight with a target price of 1,650.0p.
Read more4 Sep 2020 12:04
LONDON MARKET MIDDAY: Stocks Rise As All Eyes Turn To US Jobs Report
LONDON MARKET MIDDAY: Stocks Rise As All Eyes Turn To US Jobs Report
Read more4 Sep 2020 10:50
Barclays upgrades Hikma after US court ruling
(Sharecast News) - Barclays upgraded Hikma Pharmaceuticals to 'overweight' and increased its price target on the company's shares after a US court ruled in favour of the generic drugmaker's treatment for heart conditions.
Read more4 Sep 2020 09:36
UK BROKER RATINGS SUMMARY: Upgrades For Hikma And Imperial Brands
UK BROKER RATINGS SUMMARY: Upgrades For Hikma And Imperial Brands
Read more4 Sep 2020 07:54
LONDON BRIEFING: Ryanair Raises Funds, Eyeing Post-Virus Opportunities
LONDON BRIEFING: Ryanair Raises Funds, Eyeing Post-Virus Opportunities
Read more3 Sep 2020 18:38
US court of appeals upholds ruling in favour of Hikma over Vascepa
(Sharecast News) - US courts ruled against an appeal by Amarin related to Hikma Pharmaceuticals's generic treatment for heart conditions, Vascepa.
Read more3 Sep 2020 17:49
Hikma Receives Favourable Court Ruling For Its Generic Vascepa
Hikma Receives Favourable Court Ruling For Its Generic Vascepa
Read more17 Aug 2020 10:27
Ex-divs to take 7.7 points off FTSE 100 on 20 August
By Joice Alves LONDON, Aug 17 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current ma...
Read more13 Aug 2020 16:04
7 Aug 2020 17:05
LONDON MARKET CLOSE: FTSE Edges Up After Better-Than-Forecast US Jobs
LONDON MARKET CLOSE: FTSE Edges Up After Better-Than-Forecast US Jobs
Read more